Hemopexin mitigates doxorubicin cardiotoxicity by preserving cardiac metabolism while maintaining antitumor efficacy in a mouse model of breast cancer
20 June 2026 (13:15 - 14:15)
Organised by: 
Abstract
Slides
About the speaker
Molecular Biotechnology Centre, Turin (Italy)
4 More presentations in this session
Mrs B. Eksi (Heidelberg, DE)
Professor C. Nebigil (Strasbourg, FR)
Doctor F. Scavello (Rozzano, IT)
Professor Y. Liu (Tainan, TW)
Access the full session
The Event
ESC Cardio-Oncology 2026
20 June 2026
13:15 CET
